Lavi Erisson, Gensaic CEO
March 3, 2025 09:20 AM EST
Deals
AI

No­vo Nordisk signs $354M part­ner­ship with AI-guid­ed biotech for ‘risky’ new meta­bol­ic mech­a­nisms

Elizabeth Cairns

Senior biopharma journalist

No­vo Nordisk has formed a $354 mil­lion re­search col­lab­o­ra­tion with Gen­sa­ic, the pro­tein de­sign com­pa­ny said on Mon­day, as the Dan­ish …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

Teenag­er dies af­ter re­ceiv­ing Sarep­ta ther­a­py; Im­muno­vant gets Phase 3 win, but shifts fo­cus; Al­ny­lam’s big mo­ment; ...

Liv­er can­cer drug com­bo gets sec­ond FDA re­jec­tion over man­u­fac­tur­ing is­sues

Trump think tank res­ur­rects in­ter­na­tion­al drug pric­ing mod­el to go af­ter 'glob­al free­load­ing'

Al­ny­lam hopes its broad AT­TR-CM la­bel can give Amvut­tra an edge in heart dis­ease

BAR­DA can­cels an­nu­al bio­med­ical event for in­dus­try, gov­ern­ment reps

The buildup to Chimerix's $935M ex­it to Jazz, with more than half a dozen par­ties in­trigued

A service from the Financial Times